WO2012147095A2 - Herbal medicaments - Google Patents
Herbal medicaments Download PDFInfo
- Publication number
- WO2012147095A2 WO2012147095A2 PCT/IN2012/000229 IN2012000229W WO2012147095A2 WO 2012147095 A2 WO2012147095 A2 WO 2012147095A2 IN 2012000229 W IN2012000229 W IN 2012000229W WO 2012147095 A2 WO2012147095 A2 WO 2012147095A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medicament
- indigofera
- linifolia
- followed
- powder
- Prior art date
Links
- 239000003814 drug Substances 0.000 title claims abstract description 110
- 208000001132 Osteoporosis Diseases 0.000 claims abstract description 53
- 244000019135 Indigofera linifolia Species 0.000 claims abstract description 48
- 208000010392 Bone Fractures Diseases 0.000 claims abstract description 46
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 42
- 241000196324 Embryophyta Species 0.000 claims abstract description 38
- 210000000963 osteoblast Anatomy 0.000 claims abstract description 28
- 230000035755 proliferation Effects 0.000 claims abstract description 24
- 230000011164 ossification Effects 0.000 claims abstract description 22
- 230000001737 promoting effect Effects 0.000 claims abstract description 19
- 235000015872 dietary supplement Nutrition 0.000 claims abstract description 7
- 238000005728 strengthening Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 34
- 239000000843 powder Substances 0.000 claims description 30
- 239000000203 mixture Substances 0.000 claims description 29
- 238000007796 conventional method Methods 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 24
- 238000007873 sieving Methods 0.000 claims description 22
- 239000007787 solid Substances 0.000 claims description 20
- 241001465754 Metazoa Species 0.000 claims description 18
- 238000001035 drying Methods 0.000 claims description 17
- 238000000605 extraction Methods 0.000 claims description 16
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 241000282414 Homo sapiens Species 0.000 claims description 10
- 239000002671 adjuvant Substances 0.000 claims description 10
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 10
- 239000002904 solvent Substances 0.000 claims description 10
- 238000005406 washing Methods 0.000 claims description 10
- 238000000227 grinding Methods 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 238000001704 evaporation Methods 0.000 claims description 8
- 230000008020 evaporation Effects 0.000 claims description 8
- 238000001990 intravenous administration Methods 0.000 claims description 7
- 238000007920 subcutaneous administration Methods 0.000 claims description 7
- 235000005911 diet Nutrition 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 230000002195 synergetic effect Effects 0.000 claims description 4
- 230000000378 dietary effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 239000008247 solid mixture Substances 0.000 claims description 2
- 238000001256 steam distillation Methods 0.000 claims description 2
- 239000013589 supplement Substances 0.000 claims description 2
- 206010017076 Fracture Diseases 0.000 abstract description 26
- 230000000845 anti-microbial effect Effects 0.000 abstract description 11
- 210000002414 leg Anatomy 0.000 description 14
- 229940079593 drug Drugs 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 235000008216 herbs Nutrition 0.000 description 9
- 239000000243 solution Substances 0.000 description 8
- 239000003921 oil Substances 0.000 description 7
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 6
- 235000017491 Bambusa tulda Nutrition 0.000 description 6
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 6
- 244000082204 Phyllostachys viridis Species 0.000 description 6
- 239000011425 bamboo Substances 0.000 description 6
- 210000002805 bone matrix Anatomy 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 241000132012 Atractylodes Species 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 4
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 4
- 244000020518 Carthamus tinctorius Species 0.000 description 4
- 235000001287 Guettarda speciosa Nutrition 0.000 description 4
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 4
- 239000011575 calcium Substances 0.000 description 4
- 229910052791 calcium Inorganic materials 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- 238000002483 medication Methods 0.000 description 4
- 244000061520 Angelica archangelica Species 0.000 description 3
- 241000283690 Bos taurus Species 0.000 description 3
- 241001116742 Drynaria Species 0.000 description 3
- 241000220485 Fabaceae Species 0.000 description 3
- 239000004863 Frankincense Substances 0.000 description 3
- 241001062009 Indigofera Species 0.000 description 3
- 108090000573 Osteocalcin Proteins 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000033558 biomineral tissue development Effects 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 235000021374 legumes Nutrition 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 210000002997 osteoclast Anatomy 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 2
- WTPPRJKFRFIQKT-UHFFFAOYSA-N 1,6-dimethyl-8,9-dihydronaphtho[1,2-g][1]benzofuran-10,11-dione;1-methyl-6-methylidene-8,9-dihydro-7h-naphtho[1,2-g][1]benzofuran-10,11-dione Chemical compound O=C1C(=O)C2=C3CCCC(=C)C3=CC=C2C2=C1C(C)=CO2.O=C1C(=O)C2=C3CCC=C(C)C3=CC=C2C2=C1C(C)=CO2 WTPPRJKFRFIQKT-UHFFFAOYSA-N 0.000 description 2
- 241000173529 Aconitum napellus Species 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 241000382455 Angelica sinensis Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 229940122361 Bisphosphonate Drugs 0.000 description 2
- 208000006386 Bone Resorption Diseases 0.000 description 2
- 241000717739 Boswellia sacra Species 0.000 description 2
- 241000131329 Carabidae Species 0.000 description 2
- 244000037364 Cinnamomum aromaticum Species 0.000 description 2
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 2
- 240000007311 Commiphora myrrha Species 0.000 description 2
- 235000006965 Commiphora myrrha Nutrition 0.000 description 2
- 241000123589 Dipsacus Species 0.000 description 2
- 235000015468 Lycium chinense Nutrition 0.000 description 2
- 244000241872 Lycium chinense Species 0.000 description 2
- 235000010654 Melissa officinalis Nutrition 0.000 description 2
- 244000062730 Melissa officinalis Species 0.000 description 2
- 235000007265 Myrrhis odorata Nutrition 0.000 description 2
- 241000180649 Panax notoginseng Species 0.000 description 2
- 235000003143 Panax notoginseng Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 239000012675 alcoholic extract Substances 0.000 description 2
- 239000003263 anabolic agent Substances 0.000 description 2
- 229940124325 anabolic agent Drugs 0.000 description 2
- 150000004663 bisphosphonates Chemical class 0.000 description 2
- 230000010256 bone deposition Effects 0.000 description 2
- 230000024279 bone resorption Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000001582 osteoblastic effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000000664 rectum Anatomy 0.000 description 2
- 244000132619 red sage Species 0.000 description 2
- 229940095743 selective estrogen receptor modulator Drugs 0.000 description 2
- 239000000333 selective estrogen receptor modulator Substances 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 229940037128 systemic glucocorticoids Drugs 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229960003604 testosterone Drugs 0.000 description 2
- 229940098465 tincture Drugs 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- 241001671653 Aconitum carmichaelii Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 241001127714 Amomum Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241000717682 Anisomeles Species 0.000 description 1
- 241000984061 Aquilaria Species 0.000 description 1
- 241000271309 Aquilaria crassna Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000489492 Arisaema Species 0.000 description 1
- 235000017965 Asarum canadense Nutrition 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000020084 Bone disease Diseases 0.000 description 1
- 206010064210 Bone fissure Diseases 0.000 description 1
- 206010065687 Bone loss Diseases 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 240000007551 Boswellia serrata Species 0.000 description 1
- 206010006956 Calcium deficiency Diseases 0.000 description 1
- 235000009810 Chaenomeles cathayensis Nutrition 0.000 description 1
- 240000008918 Chaenomeles cathayensis Species 0.000 description 1
- 208000003044 Closed Fractures Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 240000006766 Cornus mas Species 0.000 description 1
- 235000000385 Costus speciosus Nutrition 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 235000018109 Cyperus longus Nutrition 0.000 description 1
- 244000150195 Cyperus longus Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 208000036119 Frailty Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000533849 Gleditsia Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 206010018720 Greenstick fracture Diseases 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 241000725145 Homalomena Species 0.000 description 1
- 241000047795 Hydrangea ampla Species 0.000 description 1
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 description 1
- 235000013422 Kaempferia rotunda Nutrition 0.000 description 1
- 244000062250 Kaempferia rotunda Species 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 244000248825 Peltandra virginica Species 0.000 description 1
- 235000001188 Peltandra virginica Nutrition 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 241001180876 Saposhnikovia Species 0.000 description 1
- 235000005010 Scirpus paludosus Nutrition 0.000 description 1
- 244000058416 Scirpus paludosus Species 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010039984 Senile osteoporosis Diseases 0.000 description 1
- 206010061363 Skeletal injury Diseases 0.000 description 1
- 241000913745 Spatholobus Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 240000004824 Trimezia steyermarkii Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000009108 Urtica dioica Nutrition 0.000 description 1
- 244000274883 Urtica dioica Species 0.000 description 1
- 241000606265 Valeriana jatamansi Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 235000014687 Zingiber zerumbet Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 230000000123 anti-resoprtive effect Effects 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000002617 bone density conservation agent Substances 0.000 description 1
- DSSYKIVIOFKYAU-UHFFFAOYSA-N bornanone Natural products C1CC2(C)C(=O)CC1C2(C)C DSSYKIVIOFKYAU-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000008989 cinnamomi cortex Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000009136 dragon's blood Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 241001233061 earthworms Species 0.000 description 1
- 230000002876 effect on osteoporosis Effects 0.000 description 1
- 238000009164 estrogen replacement therapy Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000321 herbal drug Substances 0.000 description 1
- 239000012676 herbal extract Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 description 1
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000017807 phytochemicals Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229930000223 plant secondary metabolite Natural products 0.000 description 1
- 235000017924 poor diet Nutrition 0.000 description 1
- 208000001685 postmenopausal osteoporosis Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960004622 raloxifene Drugs 0.000 description 1
- GZUITABIAKMVPG-UHFFFAOYSA-N raloxifene Chemical compound C1=CC(O)=CC=C1C1=C(C(=O)C=2C=CC(OCCN3CCCCC3)=CC=2)C2=CC=C(O)C=C2S1 GZUITABIAKMVPG-UHFFFAOYSA-N 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000004722 stifle Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 235000013522 vodka Nutrition 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Definitions
- the present invention relates to herbal medicaments.
- the invention relates to the herbal medicaments for treatment of fracture, dislocation or osteoporosis or similar medical conditions by proliferation of osteoblasts and influencing osteogenesis.
- the invention also relates to the herbal medicaments showing antimicrobial activity.
- Fracture is a medical condition in which there is a break in the continuity of the bone. Normally the break is complete but at times the bone may only be cracked or bent. This is called a greenstick fracture and is extremely painful, often more painful than a complete break.
- the most common cause of fractures is direct force, and in animals including human being, this is usually due to being hit by an automobile (car, truck, train etc). Other causes are falls, being dropped (or thrown), being stepped on or kicked and getting the leg caught while the body is still in motion. All fractures need immediate attention.
- Osteoporosis is a disease of bones that leads to an increased risk of fracture.
- BMD bone mineral density
- BMD bone microarchitecture
- DXA World Health Organization
- established osteoporosis includes the presence of a fragility fracture.
- the disease may be classified as primary type 1 , primary type 2, or secondary.
- the form of osteoporosis most common in women after menopause is referred to as primary type 1 or postmenopausal osteoporosis.
- osteoporosis Primary type 2 osteoporosis or senile osteoporosis occurs after age 75 and is seen in both females and males at a ratio of 2: 1. Finally, secondary osteoporosis may arise at any age and affects men and women equally. This form of osteoporosis results from chronic predisposing medical problems or disease, or prolonged use of medications such as glucocorticoids, when the disease is called steroid- or glucocorticoids-induced osteoporosis (SIOP or GIOP). Because it can greatly increase the risk of fragility fracture, osteoporosis may significantly affect life expectancy and quality of life.
- SIOP glucocorticoids-induced osteoporosis
- Osteoporosis risks can be reduced with lifestyle changes and sometimes medication; in people with osteoporosis, treatment may involve both. Lifestyle change includes diet and exercise, and preventing falls. Medication includes calcium, vitamin D, bisphosphonates and several others. Osteoporosis is a component of the frailty syndrome.
- Osteoporosis is Bone-thinning disease. Usually, in osteoporosis, the osteoblastic activity in the bone is less than normal, and consequently the rate of bone deposition is reduced. This results in brittle bones in the elderly, and, therefore, their bones are more susceptible to fracture. Older people may also develop a hump in the upper back, often referred to as a dowager's hump. Some women can lose as much as one-third of their skeletal structure by age 75. This is twice the rate of bone loss in older men, who have about 30% more bone mass to start with. Osteoporosis afflicts more people than any other bone disease. There are many causes of osteoporosis:
- Ossification is the formation of bone by the activity of osteoblasts and osteoclasts and the addition of minerals and salts.
- osteoblasts are found on the outer surfaces of the bones and in the bone cavities. A small amount of osteoblastic activity occurs continually in all living bones (on about 4% of all surfaces at any given time) so that at least some new bone is being formed constantly.
- the rates of bone deposition and absorption are equal to each other so that the total mass of bone remains constant. However, if the rate of bone resorption by osteoclasts exceeds that of bone formation by the osteoblasts it results in bone fragility and susceptibility to fractures.
- bisphosphonates can be used in cases of very high risk.
- Other medicines prescribed for prevention of osteoporosis include raloxifene, a selective estrogen receptor modulator (SERM).
- SERM selective estrogen receptor modulator
- Estrogen replacement therapy remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well.
- hypogonadal men testosterone has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.
- Dislocations are less common than fractures in the domestic animal. It may not be possible to decide if the limb is fractured or dislocated so if in doubt treat as a fracture.
- Anterior cruciate rupture is an extremely common injury . It is due to the tearing of one of the ligaments within the stifle (knee). The domestic animal may rupture their cruciate if they flip over a fence while jumping over it.
- Herba Epimedii is a Traditional Chinese Medicine herb and it is used in treating Osteoporosis.
- HEP Herba Epimedii
- Several researchers have noted that hebal medicine sometimes omit some of the active compounds found in the herb itself and also some include concentrations of icariin , a substance implicated in toxicity.
- the herbs like Nettle, oatstraw and horsetail are helpful to speed healing of fractures.
- Patent Publication No. CN 101244226 discloses the Chinese herbal medicine composition for curing the impairment.
- the medicament comprises of Kusnezoff Monkshood Root, Common Monkshood Mother Root, herb of siebold wildginger , clove , rhizoma sparganii , Rhizoma Zedoariae , resurrectionlily , dragon's blood , Panax notoginseng , Angelica , Cercis Bark , bibo , cassia bark , Small Gleditsia Fruit , common aucklandia root, olibanum, myrrh , bornanone, camphol, Pyritum and safflower. These ingredients are grinded to make power for use after sun-drying or drying.
- Patent Publication No. CN 101244155 relates to the herbal drug for oral as well as topical administration for bone injury treatment.
- the oral composition comprises of angelica sinensis, rhiaoma liguistici, safflower, angelica, eagle wood, drynaria, Chinese wolfberry root-bark, atractylodes, danshen root, rhizome polygoni cuspidati, divaricate saposhnikovia root, ramulus mod and Mujian.
- the topical composition comprises of angelica sinensis, rhiaoma liguistici, largehead atractylodes rhizome, oyster, safflower, angelica, panpax notoginseng, atractylodes, north Indian epimeredi herb, Xiangfu, Chinese wolfberry root-bark, ramulus mori, danshen root, radix scrophulariae, radix saussureae lappae.
- the patent publication No. CN 101 152468 describes the Chinese traditional medicine for curing closed fracture of the four limbs.
- the medicine comprises of Guangdong earthworms, ground beetles, borneol, brown sugar, distilled spirit and wheat flour.
- the Patent publication No. CN 101 152397 also discloses Chinese traditional medicine for curing fracture.
- the medicine comprised of rhizome of rehmannia, milk vetch root, yam, pulp of dogwood fruit, tuckahoe, angelica, chuanxiong rhizome peony, rhizome of drynaria, himalayan teasel root, nutgrass galingale rhizome, orange peel, liquorice.
- auxiliary ingredients like common aucklandia root; white cardamon fruit and villous amomum fruit; Scutellaria root; hawthorn and medicated leaven are used under the situation of qi stagnation; spleen deficiency and rheumatism; heat of wetting; indigestion respectively.
- Patent Publication No. CN 1785331 discloses the Chinese medicine for treating bone fracture and osteomiosis which is prepared from fourteen Chinese-medicinal materials including arisaema tuber, Sichuan aconite root, pinellia tuber, spatholobus stem, etc through washing, drying in sun, grinding and immersing in wine.
- Patent Publication No. CN 1631428 discloses the Chinese herbal composition for treating bone fracture and bone fissure.
- the composition consisting of frankincense, myrrh, safflower, peach kernels, dried body of ground beetle, native copper, dipsacus root, Schizophragma integrifolium, cassia twig, honeysuckle flower, cortex acanthopanacis, gen-seng, white atractylodes rhizome, Chinese flowering quince, drynaria, homalomena rhizoma, and dragon's bone.
- the composition can be prepared into powder, decoction, electuary, tablet, oral liquid, honeyed bolus, and water-paste pill.
- the composition is composed of Lactucae Sativae Semen 0.1 -1 , Aquilaria Lignum 2-20, Oryzae Fructus Germinatus 1 -5, Olibanum 0.1-1 , Atractylodis Ovatae Rhizoma 0.1 -1 , and Cuscutae Semen 0.1 -1.
- Patent Publication No. KR 20020068126 containing herbal extract of several herbal medicines such as Astragali Radix, Ginseng Radix, Carthami Flos, Angelicae Gigantis Radix, Cnidii Rhizoma, Rehmanniae Radix Preparata, Paeoniae Radix and Cinnamomi Cortex Spissus.
- This composition is for oral administration for bone fracture.
- An object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions.
- Another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis.
- Yet another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said medicaments may be administered orally or topically or by any suitable method.
- Still another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said medicaments are economic and efficient.
- An additional object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said medicaments are useful in the treatment of human being as well as in the field of veterinary.
- Another additional object of the invention is to provide herbal medicaments which also show antimicrobial activity.
- Yet another additional object of the invention is to provide method for the preparation of herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said method is simple to carry out and less costly.
- Still another additional object of the invention is to provide a dietary supplement which can be consumed by animals including human beings who are at a high risk of osteoporosis to increase mineralization of bone matrix and increase the expression of osteocalcin gene; thereby strengthening the bones and hence prevent fracture and provide healthy life.
- Embodiments of the invention are not mutually exclusive, but may be implemented in various combinations.
- the described embodiments of the invention and the disclosed examples are given for the purpose of illustration rather than limitation of the invention as set forth the appended claims. Further the terms disclosed embodiments are merely exemplary methods of the invention, which may be embodied in various forms.
- bra medicament intends to cover herbal composition or medicament useful for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis.
- herbal medicament also intends to cover herbal composition or medicament that shows antimicrobial activity.
- antimicrobial activity intends to cover activity that kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans.
- the herbal medicament of the present invention is simple, natural, attractive and convenient to use.
- the manufacture method for herbal medicament is simple and the effect is excellent; the price is low.
- the herbal medicament of the invention is useful in the treatment of bone fracture, dislocation or osteoporosis or similar conditions. Further, the herbal medicament of the invention also shows antimicrobial activity.
- Indigofera linifolia for treatment of bone fracture, dislocation or osteoporosis or similar conditions we also studied Indigofera linifolia for its antimicrobial activity.
- Fabaceae are herbs, vines, shrubs, trees, and lianas found in both temperate and tropical areas. They comprise one of the largest families of flowering plants, numbering 630 genera and 18,000 species.
- Genus Indigofera of Fabaceae family in the present invention This genus has more than 300 species, widely distributed in tropics and subtropics of Worlds.
- Genus Indigofera for preparing the herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions. It promotes proliferation of osteoblasts and thus influencing osteogenesis. It is useful in the treatment of human being as well as in the field of veterinary.
- Indigofera linifolia is Torki or Ratnamala or Ratanjot or Lai godhadi or Pandarphalli or Gudlaku or Bhangra, Motiyari or Jinkigali. It is a small herbaceous annual plant with very narrow leaves. It is found growing in rather dry localities. In wild state it is rather prostrate. It is used as fodder for animals. The whole plant paste is used to cure skin disease including febrile eruptions. The plant is also used in case of amenorrhea.
- herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
- said medicament comprising predefined amount of Indigofera linifolia.
- herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
- said medicament comprising predefined amount of Indigofera linifolia along with suitable pharmaceutically acceptable excipient, vehicle and / or adjuvant.
- the said medicament comprising 85% to 95% of Indigofera linifolia.
- said medicament comprising whole plant, seeds or combination thereof of Indigofera linifolia.
- the whole plant, seeds or combination thereof of Indigofera linifolia is used in the preparation of herbal medicament.
- use of other parts of Indigofera linifolia in the preparation of herbal medicament of the invention should be considered within the scope of the invention.
- said medicament comprising 85% to 95% of the whole plant, seeds or combination thereof of Indigofera linifolia.
- the said herbal medicament comprises 85% to 95% of the whole plant or seeds or combination thereof of Indigofera linifolia in combination with pharmaceutically acceptable excipient and / or , vehicle and / or adjuvant.
- the said medicament of the invention shows antimicrobial activity.
- the composition may comprises the extract like a whole plant extract, a rhizome extract, a leaf extract, a seed extract, a root extract, a bark extract, a flower extract, a fruit extract, and a combination thereof.
- the said medicament comprises an extract of the whole plant and / or seeds of it.
- the extract is generally prepared in a solvent, typically water, alcohol like methanol or ethanol or combination thereof. However, other solvents and solutions compatible with plant usage and habitat may also be used. Typically, 50 ml of the solvent like water, alcohol like methanol or ethanol or a mixture thereof is used for the extraction. A mixture of water and alcohol used in the extraction is in the proportion of 60:40.
- the composition promotes proliferation of osteoblast and influencing osteogenesis which results in repairing or healing of fractured bone or strengthening the bone in case of osteoporosis.
- the composition is found to be efficient and showed enhanced efficacy in animals as well as human being.
- the composition is found to be efficient and may show enhanced efficacy in the treatment of bone fracture, dislocation or osteoporosis or' similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis . It also shows antimicrobial activity.
- animals by definition are a major group of multicellular, eukaryotic organisms of the kingdom Animalia or Metazoa.
- “animal” intends to cover all the mammals including human beings, domestic pets as well as wild animals, birds, etc.
- step (a) grinding ingredients of step (a) by conventional technique followed by sieving paste or powder;
- said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
- the method optionally comprises:
- step (e) grinding all ingredients of step (d) by conventional technique followed by sieving to obtain a paste or powder; f. extracting the paste or powder of Indigofera linifolia obtained in step (e) by using solvent at a controlled temperature between 25°C to 75°C;
- step (f) optionally converting the said extract obtained in step (f) into semi-solid or solid form synergistic composition by conventional method;
- said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
- the solvent used for the extraction is typically water, alcohol such as methanol or ethanol or combination thereof.
- the solvent used for extraction is water
- other solvents and solutions compatible with plant usage and habitat may also be used.
- a mixture of water and alcohol used for the extraction is in the proportion of 60:40.
- the extraction can be carried out at a controlled temperature between 38°C to 60°C.
- the extraction can be carried out at a controlled temperature between 38°C to 45°C.
- the extract can be converted into semi solid or solid synergistic composition form by conventional method such as evaporation, lyophilization, etc.
- the method optionally comprises :
- step (i) grinding the ingredients of step (i) by conventional technique followed by sieving to obtain a paste or powder;
- step (j) subjecting the paste or powder obtained in step (j) to steam distillation;
- step (k) converting the distillate obtained in step (k) into semi-solid or solid form composition by conventional method; and m. converting the said composition obtained in step (j) or (1) with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method.
- said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
- the distillate can be converted into semi solid or solid composition form by conventional method such as evaporation, lyophilization, etc.
- the method comprises:
- step (n) o. grinding all ingredients of step (n) by conventional technique followed by sieving powder;
- step (n) extracting the powder of Indigofera linifolia obtained in step (n) by using water followed by filtering the water extract, subsequently removing the excess water of the extract by evaporation with the help of a rotary vacuum evaporator or converting the extract into fine powder by lyophilization;
- said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
- the water used for the extraction of powder of Indigofera linifolia in step (j) is in the ratio of 2: 1 (water: powder of Indigofera linifolia).
- extraction of the powder of Indigofera linifolia in step (j) is carried out by preparing the solution of powder of Indigofera linifolia, allowing to stand for 2 to 3 hours followed by stirring continuously for 30 minutes, repeating the process at least 4 times followed by filtration of the solution to obtain water extract.
- said whole plants are thoroughly washed and sieved prior to making paste and extraction.
- the composition of the present invention the whole plant and / or seeds of Indigofera linifolia is first thoroughly washed and dried well under shady condition to remove moisture. After grounding it into powder, it is sieved to remove remaining impurities.
- sterile water is used for washing.
- the said medicament can be administered orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration.
- the herbal medicament may be in the form including but not limited to tinctures, herbal wine, elixirs, tisanes, decoctions, powder, juice, syrup, granules, capsules, tablets, etc.
- the herbal medicament may be in the form including but not limited to oils, salves, balms, cream, lotion, spray, poultices and compresses, etc.
- the herbal medicament may be in the form including but not limited to intravenous injection, subcutaneous injection, etc.
- the herbal medicament may be in the form of but not limited to a solution, tablet, cream, gel, suppository, ring, etc which can be administered rectally.
- herbal active ingredient is mixed with a waxy substance that dissolves or liquefies after it is inserted into the rectum. Because the rectum's wall is thin and its blood supply rich, the drug is readily absorbed. If the medicaments that are irritating in suppository form may have to be given by injection. The medicament may be administered through vagina.
- the herbal medicament can be administered orally or topically.
- Tinctures are alcoholic extracts of herbs; usually obtained by combining 100% pure ethanol (or a mixture of 100% ethanol with water) with the herb.
- a completed tincture has ethanol percentage of at least 25% (sometimes up to 90%).
- the term tincture is sometimes applied to preparations using other solvents than ethanol.
- Herbal wine and elixirs are alcoholic extract of herbs; usually with an ethanol percentage of 12-38%.
- Herbal 1 wine is a maceration of herbs in wine, while an elixir is a maceration of herbs in spirits (e.g., vodka, grappa, etc.).
- Tisanes are hot water extracts of herb.
- Decoctions are long-term boiled extract of herb.
- Powder and Juices In this whole herb is consumed either in dried form (herbal powder), or fresh juice, (fresh leaves and other plant parts).
- Salves, oils, balms, creams and lotions Most topical applications are oil extractions of herbs. Taking a food grade oil and soaking herbs in it for anywhere from weeks to months allows certain phytochemicals to be extracted into the oil. This oil can then be made into salves, creams, lotions, or simply used as an oil for topical application.
- Poultices and compresses The whole herb (or the appropriate part of the plant) usually crushed or dried and re-hydrated with a small amount of water and then applied directly in a bandage, cloth or just as is.
- a fresh herb paste can be applied at affected site.
- Injectable form It can be made into injectable form also.
- Suppository form comprises herbal active ingredient with a waxy substance that dissolves or liquefies.
- a method of treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis comprises administration and / or application of said herbal medicament of the invention orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration.
- the dosage of the medicament of the invention is 50 gm for animal and 450 mg for human being daily once for 15 days.
- the animals are conveniently administered the medicine once daily. Treatment is continued till complete recovery.
- the animal including human being is recovered within 28 days depending upon the severity of the bone fracture, dislocation or osteoporosis or similar conditions.
- the affected area is secured with support.
- a dietary supplement for promoting the strengthening of bone and preventing the risk of fracture and providing healthy life
- said supplements comprises predefined amount of Indigofera linifolia along with suitable dietary base.
- the dietary supplement of the invention optionally comprises extract of of Indigofera linifolia along with suitable dietary base.
- the dietary supplement of the invention can be consumed by animals including human beings who are at a high risk of osteoporosis to promote the strengthening of bone and hence prevent the risk of fracture and provide healthy life.
- the herbal medicament of the invention is efficient on treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis and thus showed increased efficacy.
- the herb, Indigofera linifolia is readily available at cheaper price and make the medicament of the invention economic.
- the herbal medicament of the invention is administered orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration and showed high safety to host substantially without side effects. It also used as dietary supplement for subjects who are at a high risk of osteoporosis to promote the strengthening of .bone and hence prevent risk fracture and provide healthy life.
- the medicament also showed antimicrobial activity.
- a proliferation of osteoblasts was found to be increased and observed with maximum proliferation at lOOmg/ml.
- the medicinal found to be increasing mineralization of bone matrix and increasing the expression of osteocalcin gene. It was found that bone markers like calcium, phosphorus and alkaline phosphatase activities found to be increased.
Abstract
A herbal medicament for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis. The medicament compsiring either a whole plant or seeds or combination thereof of Indigofera
linifolia. The medicament also used as dietary supplement for promoting the strengthening of bone and preventing the risk of fracture and providing healthy life. The medicament also showing antimicrobial activity.
Description
TITLE OF THE INVENTION
Herbal medicaments
This application claims priority from Indian Patent Application No. 1047/MUM/2011 filed on 31st March 2011.
FIELD OF THE INVENTION:
The present invention relates to herbal medicaments.
Particularly, the invention relates to the herbal medicaments for treatment of fracture, dislocation or osteoporosis or similar medical conditions by proliferation of osteoblasts and influencing osteogenesis.
Particularly, the invention also relates to the herbal medicaments showing antimicrobial activity.
BACKGROUND AND PRIOR ART:
Fracture is a medical condition in which there is a break in the continuity of the bone. Normally the break is complete but at times the bone may only be cracked or bent. This is called a greenstick fracture and is extremely painful, often more painful than a complete break. The most common cause of fractures is direct force, and in animals including human being, this is usually due to being hit by an automobile (car, truck, train etc). Other causes are falls, being dropped (or thrown), being stepped on or kicked and getting the leg caught while the body is still in motion. All fractures need immediate attention.
Osteoporosis is a disease of bones that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is deteriorating, and the amount and variety of proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) as a bone mineral density that is 2.5 standard deviations or more below the mean peak bone mass (average of young, healthy adults) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture. The disease may be classified as primary type 1 , primary type 2, or secondary. The form of osteoporosis most common in women after menopause is referred to as primary type 1 or postmenopausal
osteoporosis. Primary type 2 osteoporosis or senile osteoporosis occurs after age 75 and is seen in both females and males at a ratio of 2: 1. Finally, secondary osteoporosis may arise at any age and affects men and women equally. This form of osteoporosis results from chronic predisposing medical problems or disease, or prolonged use of medications such as glucocorticoids, when the disease is called steroid- or glucocorticoids-induced osteoporosis (SIOP or GIOP). Because it can greatly increase the risk of fragility fracture, osteoporosis may significantly affect life expectancy and quality of life.
Osteoporosis risks can be reduced with lifestyle changes and sometimes medication; in people with osteoporosis, treatment may involve both. Lifestyle change includes diet and exercise, and preventing falls. Medication includes calcium, vitamin D, bisphosphonates and several others. Osteoporosis is a component of the frailty syndrome.
Osteoporosis is Bone-thinning disease. Usually, in osteoporosis, the osteoblastic activity in the bone is less than normal, and consequently the rate of bone deposition is reduced. This results in brittle bones in the elderly, and, therefore, their bones are more susceptible to fracture. Older people may also develop a hump in the upper back, often referred to as a dowager's hump. Some women can lose as much as one-third of their skeletal structure by age 75. This is twice the rate of bone loss in older men, who have about 30% more bone mass to start with. Osteoporosis afflicts more people than any other bone disease. There are many causes of osteoporosis:
1. the lack of physical stress on the bones because of less activity;
2. malnutrition, including not enough calcium in the diet, to the extent that sufficient bone matrix cannot be formed;
3. lack of vitamin C, which is necessary for osteoblasts to create healthy bone matrix;
4. the lack of estrogen secretion, which occurs in women after menopause (estrogen is also important to stimulate osteoblast activity); and
5. old age, when the body simply cannot form sufficient bone matrix.
Ossification (or osteogenesis) is the formation of bone by the activity of osteoblasts and osteoclasts and the addition of minerals and salts.
In long bones, the growth and elongation (lengthening) continue from birth through adolescence. In contrast to the lengthening of bone, the thickness and strength of bone must
continually be maintained by the body. That is, old bone must be replaced by new bone all the time. This is accomplished as bone is continually deposited by osteoblasts, while at the same time, it is continually being reabsorbed (broken down and digested by the body) by osteoclasts (Figure 5). Osteoblasts are found on the outer surfaces of the bones and in the bone cavities. A small amount of osteoblastic activity occurs continually in all living bones (on about 4% of all surfaces at any given time) so that at least some new bone is being formed constantly. Normally, in fact, except in growing bones, the rates of bone deposition and absorption are equal to each other so that the total mass of bone remains constant. However, if the rate of bone resorption by osteoclasts exceeds that of bone formation by the osteoblasts it results in bone fragility and susceptibility to fractures.
Just as for treatment, bisphosphonates can be used in cases of very high risk. Other medicines prescribed for prevention of osteoporosis include raloxifene, a selective estrogen receptor modulator (SERM). Estrogen replacement therapy remains a good treatment for prevention of osteoporosis but, at this time, is not recommended unless there are other indications for its use as well. In hypogonadal men testosterone has been shown to give improvement in bone quantity and quality, but, as of 2008, there are no studies of the effects on fractures or in men with a normal testosterone level.
There are several medications used to treat osteoporosis, depending on gender. Medications themselves can be classified as antiresorptive or bone anabolic agents. Antiresorptive agents work primarily by reducing bone resorption, while bone anabolic agents build bone rather than inhibit resorption. Lifestyle changes are an important aspect of treatment. A major problem is gaining long-term adherence to therapy from patients with osteoporosis. Fifty percent of patients do not take their medications and most discontinue within 1 year.
People in India are increasingly suffering from osteoporosis due to vitamin "D and calcium deficiency as well as a poor diet. High steroid intake also has a negative effect on osteoporosis risk. Up to 12 million Indians have osteoporosis and some of them are only 20.
In case of animals, the veterinary help is not available in rural area or even in cities; there are very few veterinary hospitals available for immediate help. In absence of veterinary help, the
animal will not be able to use the leg at all or the limb may become deformed, twisted or shortened if there is considerable delay in treatment.
Dislocations are less common than fractures in the domestic animal. It may not be possible to decide if the limb is fractured or dislocated so if in doubt treat as a fracture.
Anterior cruciate rupture is an extremely common injury . It is due to the tearing of one of the ligaments within the stifle (knee). The domestic animal may rupture their cruciate if they flip over a fence while jumping over it.
Herba Epimedii (HEP) is a Traditional Chinese Medicine herb and it is used in treating Osteoporosis. Several researchers have noted that hebal medicine sometimes omit some of the active compounds found in the herb itself and also some include concentrations of icariin , a substance implicated in toxicity.
The herbs like Nettle, oatstraw and horsetail are helpful to speed healing of fractures.
Patent Publication No. CN 101244226 discloses the Chinese herbal medicine composition for curing the impairment. The medicament comprises of Kusnezoff Monkshood Root, Common Monkshood Mother Root, herb of siebold wildginger , clove , rhizoma sparganii , Rhizoma Zedoariae , resurrectionlily , dragon's blood , Panax notoginseng , Angelica , Cercis Bark , bibo , cassia bark , Small Gleditsia Fruit , common aucklandia root, olibanum, myrrh , bornanone, camphol, Pyritum and safflower. These ingredients are grinded to make power for use after sun-drying or drying.
Patent Publication No. CN 101244155 relates to the herbal drug for oral as well as topical administration for bone injury treatment. The oral composition comprises of angelica sinensis, rhiaoma liguistici, safflower, angelica, eagle wood, drynaria, Chinese wolfberry root-bark, atractylodes, danshen root, rhizome polygoni cuspidati, divaricate saposhnikovia root, ramulus mod and Mujian. The topical composition comprises of angelica sinensis, rhiaoma liguistici, largehead atractylodes rhizome, oyster, safflower, angelica, panpax notoginseng, atractylodes, north Indian epimeredi herb, Xiangfu, Chinese wolfberry root-bark, ramulus mori, danshen root, radix scrophulariae, radix saussureae lappae.
The patent publication No. CN 101 152468 describes the Chinese traditional medicine for curing closed fracture of the four limbs. The medicine comprises of Guangdong earthworms, ground beetles, borneol, brown sugar, distilled spirit and wheat flour.
The Patent publication No. CN 101 152397 also discloses Chinese traditional medicine for curing fracture. The medicine comprised of rhizome of rehmannia, milk vetch root, yam, pulp of dogwood fruit, tuckahoe, angelica, chuanxiong rhizome peony, rhizome of drynaria, himalayan teasel root, nutgrass galingale rhizome, orange peel, liquorice. The auxiliary ingredients like common aucklandia root; white cardamon fruit and villous amomum fruit; Scutellaria root; hawthorn and medicated leaven are used under the situation of qi stagnation; spleen deficiency and rheumatism; heat of wetting; indigestion respectively.
Patent Publication No. CN 1785331 discloses the Chinese medicine for treating bone fracture and osteomiosis which is prepared from fourteen Chinese-medicinal materials including arisaema tuber, Sichuan aconite root, pinellia tuber, spatholobus stem, etc through washing, drying in sun, grinding and immersing in wine.
Patent Publication No. CN 1631428 discloses the Chinese herbal composition for treating bone fracture and bone fissure. The composition consisting of frankincense, myrrh, safflower, peach kernels, dried body of ground beetle, native copper, dipsacus root, Schizophragma integrifolium, cassia twig, honeysuckle flower, cortex acanthopanacis, gen-seng, white atractylodes rhizome, Chinese flowering quince, drynaria, homalomena rhizoma, and dragon's bone. The composition can be prepared into powder, decoction, electuary, tablet, oral liquid, honeyed bolus, and water-paste pill.
International Patent Publication No. WO03094940 provides a pharmaceutical composition to prevent and treat fracture and osteoporosis. The composition is composed of Lactucae Sativae Semen 0.1 -1 , Aquilaria Lignum 2-20, Oryzae Fructus Germinatus 1 -5, Olibanum 0.1-1 , Atractylodis Ovatae Rhizoma 0.1 -1 , and Cuscutae Semen 0.1 -1.
Patent Publication No. KR 20020068126 containing herbal extract of several herbal medicines such as Astragali Radix, Ginseng Radix, Carthami Flos, Angelicae Gigantis Radix, Cnidii
Rhizoma, Rehmanniae Radix Preparata, Paeoniae Radix and Cinnamomi Cortex Spissus. This composition is for oral administration for bone fracture.
Research is always being carried for new developments which will give more efficient medicament than that of existing one, at the same time it will be less costly and simple to produce.
Further we have not come across single reference which teach or demonstrate herbal medicaments comprising active ingredient belonging to Genus Indigofera of Fabaceae family for treatment of bone fracture, dislocation or osteoporosis or similar diseases or a medicament that would facilitate proliferation of osteoblasts and also showing antimicrobial activity.
OBJECTS OF THE INVENTION:
An object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions.
Another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis.
Yet another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said medicaments may be administered orally or topically or by any suitable method.
Still another object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said medicaments are economic and efficient.
An additional object of the invention is to provide herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of
osteoblasts and influencing osteogenesis; said medicaments are useful in the treatment of human being as well as in the field of veterinary.
Another additional object of the invention is to provide herbal medicaments which also show antimicrobial activity.
Yet another additional object of the invention is to provide method for the preparation of herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblasts and influencing osteogenesis; said method is simple to carry out and less costly.
Still another additional object of the invention is to provide a dietary supplement which can be consumed by animals including human beings who are at a high risk of osteoporosis to increase mineralization of bone matrix and increase the expression of osteocalcin gene; thereby strengthening the bones and hence prevent fracture and provide healthy life.
DETAILED DESCRIPTION OF THE INVENTION:
Before the present invention is described, it is to be understood that this invention is not limited to particular methodologies and materials described, as these may vary as per the person skilled in the art. It is also to be understood that the terminology used in the description is for the purpose of describing the particular embodiments only, and is not intended to limit the scope of the present invention.
Before the present invention is described, it is to be understood that unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. Further, it is to be understood that the present invention is not limited to the methodologies and materials similar or equivalent to those described herein can be used in the practice or testing of the present invention, the preferred methods and materials are described, as these may vary within the specification indicated. Unless stated to the contrary, any use of the words such as "including," "containing," "comprising," "having" and the like, means "including without limitation" and shall not be construed to limit any general statement that it follows to the specific or similar items or matters immediately following it. Embodiments of the invention are not mutually
exclusive, but may be implemented in various combinations. The described embodiments of the invention and the disclosed examples are given for the purpose of illustration rather than limitation of the invention as set forth the appended claims. Further the terms disclosed embodiments are merely exemplary methods of the invention, which may be embodied in various forms.
It is also understood that the terms "a", "an", "the" and like are words for the sake of convenience and are not to be construed as limiting terms. Moreover, it will be understood that the illustrations are for the purpose of describing a particular exemplary embodiment of the invention and are not limited to the invention thereto.
It is also understood that the terms "sieving", "washing", grinding", "drying", "extraction" used herein intend to cover all kinds of conventional methods used for the said purpose carried out at room temperature unless specified particularly herein.
The term "herbal medicament", as used herein, intends to cover herbal composition or medicament useful for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis.
The term "herbal medicament", as used herein, also intends to cover herbal composition or medicament that shows antimicrobial activity.
The term "antimicrobial activity", as used herein, intends to cover activity that kills or inhibits the growth of microorganisms such as bacteria, fungi, or protozoans.
The herbal medicament of the present invention is simple, natural, attractive and convenient to use. The manufacture method for herbal medicament is simple and the effect is excellent; the price is low. The herbal medicament of the invention is useful in the treatment of bone fracture, dislocation or osteoporosis or similar conditions. Further, the herbal medicament of the invention also shows antimicrobial activity.
To achieve our object of the invention, we studied Indigofera linifolia for treatment of bone fracture, dislocation or osteoporosis or similar conditions. We also studied Indigofera linifolia for its antimicrobial activity.
Fabaceae are herbs, vines, shrubs, trees, and lianas found in both temperate and tropical areas. They comprise one of the largest families of flowering plants, numbering 630 genera and 18,000 species. We are studying the Genus Indigofera of Fabaceae family in the present invention. This genus has more than 300 species, widely distributed in tropics and subtropics of Worlds. We are studying the species belongs to Genus Indigofera for preparing the herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions. It promotes proliferation of osteoblasts and thus influencing osteogenesis. It is useful in the treatment of human being as well as in the field of veterinary.
The local name of Indigofera linifolia is Torki or Ratnamala or Ratanjot or Lai godhadi or Pandarphalli or Gudlaku or Bhangra, Motiyari or Jinkigali. It is a small herbaceous annual plant with very narrow leaves. It is found growing in rather dry localities. In wild state it is rather prostrate. It is used as fodder for animals. The whole plant paste is used to cure skin disease including febrile eruptions. The plant is also used in case of amenorrhea.
According to one of embodiments of the invention; there is provided herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said medicament comprising predefined amount of Indigofera linifolia.
According to another embodiment of the invention; there is provided herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said medicament comprising predefined amount of Indigofera linifolia along with suitable pharmaceutically acceptable excipient, vehicle and / or adjuvant.
Preferably, the said medicament comprising 85% to 95% of Indigofera linifolia.
Preferably, said medicament comprising whole plant, seeds or combination thereof of Indigofera linifolia.
Particularly, the whole plant, seeds or combination thereof of Indigofera linifolia is used in the preparation of herbal medicament. However, use of other parts of Indigofera linifolia in the preparation of herbal medicament of the invention should be considered within the scope of the invention.
More preferably, said medicament comprising 85% to 95% of the whole plant, seeds or combination thereof of Indigofera linifolia.
More preferably, the said herbal medicament comprises 85% to 95% of the whole plant or seeds or combination thereof of Indigofera linifolia in combination with pharmaceutically acceptable excipient and / or , vehicle and / or adjuvant.
According to another embodiment of the invention, the said medicament of the invention shows antimicrobial activity.
Instead of paste of the whole plant or seeds or combination thereof of Indigofera linifolia, the composition may comprises the extract like a whole plant extract, a rhizome extract, a leaf extract, a seed extract, a root extract, a bark extract, a flower extract, a fruit extract, and a combination thereof.
Instead of paste or powder of the whole plant, seeds or combination thereof of Indigofera linifolia, optionally the said medicament comprises an extract of the whole plant and / or seeds of it.
The extract is generally prepared in a solvent, typically water, alcohol like methanol or ethanol or combination thereof. However, other solvents and solutions compatible with plant usage and habitat may also be used. Typically, 50 ml of the solvent like water, alcohol like methanol or ethanol or a mixture thereof is used for the extraction. A mixture of water and alcohol used in the extraction is in the proportion of 60:40.
The composition promotes proliferation of osteoblast and influencing osteogenesis which results in repairing or healing of fractured bone or strengthening the bone in case of osteoporosis. The composition is found to be efficient and showed enhanced efficacy in animals as well as human being. The composition is found to be efficient and may show enhanced efficacy in the treatment of bone fracture, dislocation or osteoporosis or' similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis . It also shows antimicrobial activity.
The animals by definition are a major group of multicellular, eukaryotic organisms of the kingdom Animalia or Metazoa. Thus, "animal" intends to cover all the mammals including human beings, domestic pets as well as wild animals, birds, etc.
According to another embodiment of the invention, there is provided a method for the preparation of herbal medicament for treatment of bone fracture, dislocation or osteoporosis or similar conditions
by promoting proliferation of osteoblast and thus influencing osteogenesis;
said method comprising :
a. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional technique;
b. grinding ingredients of step (a) by conventional technique followed by sieving paste or powder; and
c. converting the said paste or powder with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
The method optionally comprises:
d. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional technique;
e. grinding all ingredients of step (d) by conventional technique followed by sieving to obtain a paste or powder;
f. extracting the paste or powder of Indigofera linifolia obtained in step (e) by using solvent at a controlled temperature between 25°C to 75°C;
g. optionally converting the said extract obtained in step (f) into semi-solid or solid form synergistic composition by conventional method; and
h. _ converting the said composition obtained in steps (f) or (g) with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
The solvent used for the extraction is typically water, alcohol such as methanol or ethanol or combination thereof. Preferably, the solvent used for extraction is water However, other solvents and solutions compatible with plant usage and habitat may also be used. A mixture of water and alcohol used for the extraction is in the proportion of 60:40.
Particularly, the extraction can be carried out at a controlled temperature between 38°C to 60°C. Preferably, the extraction can be carried out at a controlled temperature between 38°C to 45°C.
The extract can be converted into semi solid or solid synergistic composition form by conventional method such as evaporation, lyophilization, etc.
The method optionally comprises :
i. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional means;
j. grinding the ingredients of step (i) by conventional technique followed by sieving to obtain a paste or powder;
k. subjecting the paste or powder obtained in step (j) to steam distillation;
1. converting the distillate obtained in step (k) into semi-solid or solid form composition by conventional method; and
m. converting the said composition obtained in step (j) or (1) with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method.
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
The distillate can be converted into semi solid or solid composition form by conventional method such as evaporation, lyophilization, etc.
In preferred embodiment of the invention, the method comprises:
n. sieving followed by washing and sieving again predefined amount of whole plant , seeds or combination thereof of Indigofera linifolia followed by drying by conventional technique;
o. grinding all ingredients of step (n) by conventional technique followed by sieving powder;
p. extracting the powder of Indigofera linifolia obtained in step (n) by using water followed by filtering the water extract, subsequently removing the excess water of the extract by evaporation with the help of a rotary vacuum evaporator or converting the extract into fine powder by lyophilization; and
q. converting the said powder with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
Preferably, the water used for the extraction of powder of Indigofera linifolia in step (j) is in the ratio of 2: 1 (water: powder of Indigofera linifolia).
Preferably, extraction of the powder of Indigofera linifolia in step (j) is carried out by preparing the solution of powder of Indigofera linifolia, allowing to stand for 2 to 3 hours followed by stirring continuously for 30 minutes, repeating the process at least 4 times followed by filtration of the solution to obtain water extract.
Preferably, said whole plants are thoroughly washed and sieved prior to making paste and extraction. To prepare the composition of the present invention, the whole plant and / or seeds of Indigofera linifolia is first thoroughly washed and dried well under shady condition to remove moisture. After grounding it into powder, it is sieved to remove remaining impurities. Preferably, sterile water is used for washing.
In yet another embodiment of the invention, the said medicament can be administered orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration.
In oral administration, the herbal medicament may be in the form including but not limited to tinctures, herbal wine, elixirs, tisanes, decoctions, powder, juice, syrup, granules, capsules, tablets, etc.
In topical administration, the herbal medicament may be in the form including but not limited to oils, salves, balms, cream, lotion, spray, poultices and compresses, etc.
In administration by injection, the herbal medicament may be in the form including but not limited to intravenous injection, subcutaneous injection, etc.
The herbal medicament may be in the form of but not limited to a solution, tablet, cream, gel, suppository, ring, etc which can be administered rectally. In this form, herbal active ingredient is mixed with a waxy substance that dissolves or liquefies after it is inserted into the rectum. Because the rectum's wall is thin and its blood supply rich, the drug is readily absorbed. If the medicaments that are irritating in suppository form may have to be given by injection. The medicament may be administered through vagina.
Preferably, the herbal medicament can be administered orally or topically.
Particularly, Tinctures are alcoholic extracts of herbs; usually obtained by combining 100% pure ethanol (or a mixture of 100% ethanol with water) with the herb. A completed tincture has ethanol percentage of at least 25% (sometimes up to 90%). The term tincture is sometimes applied to preparations using other solvents than ethanol.
Herbal wine and elixirs are alcoholic extract of herbs; usually with an ethanol percentage of 12-38%. Herbal1 wine is a maceration of herbs in wine, while an elixir is a maceration of herbs in spirits (e.g., vodka, grappa, etc.).
Tisanes are hot water extracts of herb.
Decoctions are long-term boiled extract of herb.
Powder and Juices: In this whole herb is consumed either in dried form (herbal powder), or fresh juice, (fresh leaves and other plant parts).
Syrups - Extracts of herbs made with syrup or honey. Sixty five parts of sugar are mixed with 35 parts of water and herb. The whole is then boiled and macerated for three weeks.
Salves, oils, balms, creams and lotions: Most topical applications are oil extractions of herbs. Taking a food grade oil and soaking herbs in it for anywhere from weeks to months allows certain phytochemicals to be extracted into the oil. This oil can then be made into salves, creams, lotions, or simply used as an oil for topical application.
Poultices and compresses: The whole herb (or the appropriate part of the plant) usually crushed or dried and re-hydrated with a small amount of water and then applied directly in a bandage, cloth or just as is.
A fresh herb paste can be applied at affected site. Injectable form: It can be made into injectable form also.
Suppository form comprises herbal active ingredient with a waxy substance that dissolves or liquefies.
According to yet another embodiment of the invention, there is provided a method of treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said treatment comprises administration and / or application of said herbal medicament of the invention orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration.
Typically, the dosage of the medicament of the invention is 50 gm for animal and 450 mg for human being daily once for 15 days. The animals are conveniently administered the medicine once daily. Treatment is continued till complete recovery. Usually, the animal including human being is recovered within 28 days depending upon the severity of the bone fracture, dislocation or osteoporosis or similar conditions. The affected area is secured with support.
From in-vitro study it was found that increase in proliferation of osteoblasts was observed with maximum proliferation at lOOgm/ml. The present medicament increased mineralization of bone matrix and increased the expression of osteocalcin gene. It is exhibited an increase in bone markers like calcium, phosphorus and alkaline phosphatase activities.
According to still another embodiment of the invention, there is provided a dietary supplement for promoting the strengthening of bone and preventing the risk of fracture and providing healthy life,
said supplements comprises predefined amount of Indigofera linifolia along with suitable dietary base.
The dietary supplement of the invention optionally comprises extract of of Indigofera linifolia along with suitable dietary base.
The dietary supplement of the invention can be consumed by animals including human beings who are at a high risk of osteoporosis to promote the strengthening of bone and hence prevent the risk of fracture and provide healthy life.
The herbal medicament of the invention is efficient on treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis and thus showed increased efficacy. The herb, Indigofera linifolia is readily available at cheaper price and make the medicament of the invention economic. The herbal medicament of the invention is administered orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration and showed
high safety to host substantially without side effects. It also used as dietary supplement for subjects who are at a high risk of osteoporosis to promote the strengthening of .bone and hence prevent risk fracture and provide healthy life. The medicament also showed antimicrobial activity.
The present invention is illustrated by the following examples, which is not intended to limit the effective scope of the invention.
Example 1
Preparation of herbal medicament of the invention
900g of whole plant of Indigofera linifolia was sieved followed by washed and sieved again followed by drying under shady condition. This whole plant was grounded to obtain paste with water (q.s.). The paste was sieved. 50gm of the paste was given orally to cattle with a fractured leg followed by securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 30 days.
Example 2:
Preparation of herbal medicament of the invention
900g of whole plant of Indigofera linifolia was sieved, washed and sieved again followed by drying under shady condition. The whole plant was grounded to obtain paste with water (q.s.). The paste was extracted using water at temperature of 40°C. The paste was mixed with water in the ratio of 1 :2 and allowed to stand for 2 to 3 hours followed by stirring continuously for 30 minutes. The process was repeated at least 4 times. The solution was filtered. The water extract was converted into semi-solid form by evaporation with the help of rotary evaporator. 50gm of the semi solid paste was given orally to cattle with a fractured leg followed by securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 25 days.
Example 3:
Preparation of herbal medicament of the invention
900g of whole plant of Indigofera linifolia was sieved followed by washed and sieved again followed by drying under shady condition. This whole plant was grounded to obtain paste with
water (q.s.). The paste was sieved. 50gm of the paste was given orally orally to Buffalo with a fractured leg followed by securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 32 days.
Example 4:
Preparation of herbal medicament of the invention
900g of whole plant of Indigofera linifolia was sieved, washed and sieved again followed by drying under shady condition. The whole plant was grounded to obtain paste with water (qs). The paste was extracted using water at temperature of 65°C. The paste was mixed with water in the ratio of 1 :2 and allowed to stand for 2 to 3 hours followed by stirring continuously for 30 minutes, The process was repeated at least 4 times. The solution was filtered. The water extract was converted into semi-solid form by evaporation with the help of rotary evaporator. 50gm of the semi solid paste was given orally to cattle with a fractured leg followed by securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 27 days.
Example 5:
Preparation of herbal medicament of the invention
900gms of whole plant of Indigofera linifolia was sieved followed by washed and sieved again followed by drying under shady condition. This whole plant was grounded to obtain paste with water (q.s.). The paste was sieved. 5gm of the paste was given orally to a patient with a fractured leg followed by securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 45 days.
Example 6:
Preparation of herbal medicament of the invention
900 gms of whole plant of Indigofera linifolia was sieved, washed and sieved again followed by drying under shady condition. The whole plant was grounded to obtain paste with water (qs). The paste was extracted using water at temperature of 65°C. The paste was mixed with water in the ratio of 1 :2 and allowed to stand for 2 to 3 hours followed by stirring continuously for 30 minutes, The process was repeated at least 4 times. The solution was filtered. The water extract was converted into semi-solid form by evaporation with the help of rotary evaporator. 5gm of the semi solid paste was given orally to patient with a fractured leg followed by
securing the fractured area with Bamboo splints once in a day till the fracture heals. It was observed that leg healed within 39 days.
We have carried out invitro testing after administration of the medicament of the invention. A proliferation of osteoblasts was found to be increased and observed with maximum proliferation at lOOmg/ml. The medicinal found to be increasing mineralization of bone matrix and increasing the expression of osteocalcin gene. It was found that bone markers like calcium, phosphorus and alkaline phosphatase activities found to be increased.
The present invention as described above, it is to be understood that this invention is not limited to particular methodologies and materials described, as these may vary as per the person skilled in the art. It is also to be understood that the terminology used in the description is for the purpose of describing the particular embodiments only, and is not intended to limit the scope of the present invention.
Claims
1. A herbal medicaments for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said medicament comprising predefined amount of Indigofera linifolia.
2. The herbal medicaments as claimed in claim 1 , wherein said medicament comprising predefined amount of Indigofera linifolia along with suitable pharmaceutically acceptable excipient, vehicle and / or adjuvant.
3. The herbal medicaments as claimed in claim 1 , wherein preferably said medicament comprising 85% to 95% of Indigofera linifolia.
4. The herbal medicaments as claimed in claim 1, wherein preferably said medicament comprising whole plant, seeds or combination thereof of Indigofera linifolia.
5. The herbal medicaments as claimed in claim 1, wherein preferably said medicament comprising the extract of the whole plant or seeds or combination thereof of Indigofera linifolia.
6. A method for the preparation of herbal medicament for treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said method comprising :
a. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional technique;
b. grinding ingredients of step (a) by conventional technique followed by sieving paste or powder; and
c. converting the said paste or powder with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
7. The method as claimed in claim 6, wherein the method optionally comprises:
d. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional technique;
e. grinding all ingredients of step (d) by conventional technique followed by sieving to obtain a paste or powder;
f. extracting tha paste or powder of Indigofera linifolia obtained in step (e) by using solvent at a controlled temperature between 25°C to 75°C;
g. optionally converting the said extract obtained in step (f) into semi-solid or solid form synergistic composition by conventional method; and
h. converting the said composition obtained in steps (f) or (g) with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
8. The method as claimed in claim 7, wherein the solvent used for the extraction is typically water, alcohol such as methanol or ethanol or combination thereof.
9. The method as claimed in claim 7, wherein the extraction step (f) can be carried out particularly at a controlled temperature between 38°C to 60°C.
10. The method as claimed in claim 7, wherein the extract can be converted into semi solid or solid synergistic composition form by conventional method such as evaporation, lyophilization, and the like.
1 1. The method as claimed in claim 7, wherein extraction of the powder of Indigofera linifolia in step (j) is carried out by preparing the solution of powder of Indigofera linifolia, allowing to stand for 2 to 3 hours followed by stirring continuously for 30 minutes, repeating the process at least 4 times followed by filtration of the solution to obtain water extract.
12. The method as claimed in claim 7, wherein the water used for the extraction of powder of Indigofera linifolia in step (j) is in the ratio of 2: 1 (water: powder of Indigofera linifolia).
13. The method as claimed in claim 6, wherein the method optionally comprises:
i. sieving followed by washing and sieving again predefined amount of whole plant, seeds or combination thereof of Indigofera linifolia followed by drying by conventional means;
j. grinding the ingredients of step (i) by conventional technique followed by sieving to obtain a paste or powder;
k. subjecting the paste or powder obtained in step (j) to steam distillation;
1. converting the distillate obtained in step (k) into semi-solid or solid form composition by conventional method; and
m. Converting the said composition obtained in step (j) or (1) with or without pharmaceutically acceptable excipient, vehicle and / or adjuvant into medicament by conventional method;
said medicament for administering orally or topically or rectally, or vaginally or injectable including intravenous, subcutaneous, etc or by any other suitable route of administration.
14. The method as claimed in claim 13, wherein the distillate can be converted into semi solid or solid composition form by conventional method such as evaporation, lyophilization, etc.
15. A method of treatment of bone fracture, dislocation or osteoporosis or similar conditions by promoting proliferation of osteoblast and thus influencing osteogenesis;
said treatment comprises administration and / or application of said herbal medicament as claimed in any of the preceding claims orally or topically or injected intravenously, subcutaneously, etc or by any other suitable route of administration.
16. The method of treatment as claimed in claim 1 , wherein the dosage of the medicament is 50 gm for. animal and 450 mg for human being daily once for 15 days.
17. A dietary supplement for promoting the strengthening of bone and preventing the risk . of fracture and providing healthy life,
said supplements comprises predefined amount of Indigofera linifolia along with suitable dietary base.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1047MU2011 | 2011-03-31 | ||
IN1047/MUM/2011 | 2011-03-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2012147095A2 true WO2012147095A2 (en) | 2012-11-01 |
WO2012147095A3 WO2012147095A3 (en) | 2013-03-21 |
Family
ID=46881116
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2012/000229 WO2012147095A2 (en) | 2011-03-31 | 2012-03-30 | Herbal medicaments |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2012147095A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109223984A (en) * | 2017-07-11 | 2019-01-18 | 龙广辉 | A method of making liquid medicine |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020068126A (en) | 2001-02-20 | 2002-08-27 | 홍종수 | Extracts from crude drug having an activity of treating injury and pharmaceutical compositions or health food comprising the same |
WO2003094940A1 (en) | 2002-05-14 | 2003-11-20 | Sagittarius Life Science Corp. | Medicament for prevention and treatment of fracture and osteoporosis |
CN1631428A (en) | 2004-12-20 | 2005-06-29 | 李国杰 | Chinese herbal composition for treating bone fracture and bone fissure |
CN1785331A (en) | 2005-10-15 | 2006-06-14 | 杜运友 | Chinese herbal medicine composition for treating bone fracture and osteomiosis |
CN101152468A (en) | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating membra closure type bone fracture |
CN101152397A (en) | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating slow concrescence of bone fracture |
CN101244226A (en) | 2008-02-18 | 2008-08-20 | 刘奇 | Chinese medicine composition for treating traumatic injury |
CN101244155A (en) | 2008-01-28 | 2008-08-20 | 陈良美 | Medicament for treating bone fracture |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1153583C (en) * | 2001-03-26 | 2004-06-16 | 张祥明 | Bone-setting pill 'Jiegudan' |
-
2012
- 2012-03-30 WO PCT/IN2012/000229 patent/WO2012147095A2/en active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020068126A (en) | 2001-02-20 | 2002-08-27 | 홍종수 | Extracts from crude drug having an activity of treating injury and pharmaceutical compositions or health food comprising the same |
WO2003094940A1 (en) | 2002-05-14 | 2003-11-20 | Sagittarius Life Science Corp. | Medicament for prevention and treatment of fracture and osteoporosis |
CN1631428A (en) | 2004-12-20 | 2005-06-29 | 李国杰 | Chinese herbal composition for treating bone fracture and bone fissure |
CN1785331A (en) | 2005-10-15 | 2006-06-14 | 杜运友 | Chinese herbal medicine composition for treating bone fracture and osteomiosis |
CN101152468A (en) | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating membra closure type bone fracture |
CN101152397A (en) | 2007-09-15 | 2008-04-02 | 尹克华 | Traditional Chinese medicine for treating slow concrescence of bone fracture |
CN101244155A (en) | 2008-01-28 | 2008-08-20 | 陈良美 | Medicament for treating bone fracture |
CN101244226A (en) | 2008-02-18 | 2008-08-20 | 刘奇 | Chinese medicine composition for treating traumatic injury |
Also Published As
Publication number | Publication date |
---|---|
WO2012147095A3 (en) | 2013-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101543248A (en) | A cold tea especially suitable for 'three high and one acid' population and method for its prepairing | |
CN101829278B (en) | Quick antiphlogistic and analgesic Chinese herbal preparation | |
KR100688252B1 (en) | Composition for improving male sexual function | |
CN1196948A (en) | Full presciption medicine for treating rheumatism disease | |
CN102416145B (en) | Chinese medicinal composition for treating menstrual disorder | |
CN101337019A (en) | Oral traditional Chinese medicine formulation for treating herpes zoster post herpetic neuralgia and preparation method thereof | |
CN100387291C (en) | Medicine for treating pulmonary tuberculosis | |
CN104042774A (en) | Medicine composition for treatment of osteoporosis | |
CN103550688A (en) | Traditional Chinese medicine (TCM) composition for treating palpitation | |
WO2012147095A2 (en) | Herbal medicaments | |
KR100522176B1 (en) | Composition for improving male sexual function | |
CN109876127A (en) | A kind of blood-nourishing angelica capsules and preparation method thereof | |
CN103239646B (en) | Chinese medicine effective part composition for treating leucoderma and preparation method thereof | |
CN102552503B (en) | Traditional Chinese medicine powder used for treating cervical erosion | |
CN103142898B (en) | Preparation method of medicine used after esophageal achalasia operation | |
CN103007236B (en) | Chinese medicinal composition for treating ankylosing spondylitis | |
CN101623346A (en) | Chinese medicinal composition for treating acute lumbar injury | |
CN1320900C (en) | Bone erosion renewel pill | |
CN1183918C (en) | Medicine for curing protrution of intervetebral disc and its preparing method | |
CN105055816A (en) | Traditional Chinese medicine composite for treating cerebral thrombosis and preparation method thereof | |
CN105250629A (en) | Traditional Chinese medicine composition for treating cerebral thrombosis and preparing method thereof | |
CN1415363A (en) | Biochemical medicament of araliaceae plant and its preparation method | |
CN104547865A (en) | Application of traditional Chinese medicine preparation in preparing medicine for treating senile dementia | |
CN103157040A (en) | Pharmaceutical composition for treating multiple osteoenchondroma | |
CN103191342A (en) | Method for preparing diaphyseal aclasis nursing substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 12761818 Country of ref document: EP Kind code of ref document: A2 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 12761818 Country of ref document: EP Kind code of ref document: A2 |